Healthtech funding in November 2020
European Healthtech startup funding raised during November 2020.
In November 2020, 49 European Healthtech companies closed 51 funding rounds and raised €538M in equity funding (excluding debt and grants). Debt rounds added €4.7M. Germany led by capital raised, and Kurma Partners was the most active investor. Data as of 20 Nov 2026.
Equity funding
€538M
excl. debt & grants · +€4.7M debt
Funding rounds
51
Companies
49
Top country
Germany
Rank among sectors
#5
7.4% of sector funding
Debt financing
€4.7M
0.9% of total
Top-10 round share
76.4%
of disclosed capital
Rounds ≥ €100M
1
Top countries
by € raisedHealthtech — top countries by capital, November 2020 — interactive chart.
Data table
| Healthtech — top countries by capital, November 2020 | |
|---|---|
| Germany | €161M |
| UK | €115M |
| Switzerland | €100M |
| Israel | €59M |
| Sweden | €31M |
| Poland | €24M |
| France | €23M |
| Spain | €18M |
Stage mix
by € raisedHealthtech — stage mix, November 2020 — interactive chart.
Data table
| Healthtech — stage mix, November 2020 | |
|---|---|
| Series C | €189M |
| Other | €124M |
| Seed | €61M |
| Series A | €58M |
| Series D+ | €52M |
| Series B | €25M |
| Growth/Late | €22M |
| Debt | €4.7M |
| Crowdfunding | €3.6M |
| Early VC | €2.4M |
| Grant | €2.3M |
| Pre-Seed | €535k |
Top deals
largest disclosed rounds in November 2020| Company | Stage | Date | Amount |
|---|---|---|---|
| Atai Life Sciences | Series C | Nov 2020 | €105M |
| Pharvaris | Series C | Nov 2020 | €67M |
| Achilles Therapeutics | Other | Nov 2020 | €59M |
| CatalYm | Seed | Nov 2020 | €50M |
| K Health | Series D+ | Nov 2020 | €35M |
| Min Doktor | Other | Nov 2020 | €27M |
| Stilla Technologies | Series B | Nov 2020 | €20M |
| Synendos Therapeutics | Series A | Nov 2020 | €19M |
| WishBone Medical | Growth/Late | Nov 2020 | €17M |
| Endomag | Series D+ | Nov 2020 | €17M |
| Start Codon | Other | Nov 2020 | €17M |
| Biosight | Series C | Nov 2020 | €16M |
| Koa Health | Series A | Nov 2020 | €14M |
| Memo Therapeutics | Series A | Nov 2020 | €14M |
| Unmind | Series A | Nov 2020 | €8.5M |
Top investors
most active in November 2020, by deal count- Kurma Partners2 deals
- Alameda Ventures1 deals
- Alto Invest1 deals
- Ancora Finance Group1 deals
- Auriga Partners1 deals
- BStartup Health1 deals
- Cadence Growth Capital1 deals
- Cleverage Venture Capital1 deals
- Draper Esprit1 deals
- Future Planet Capital1 deals